Literature DB >> 1824775

Genetic analysis of diabetes in the nonobese diabetic mouse. I. MHC and T cell receptor beta gene expression.

A Livingstone1, C T Edwards, J A Shizuru, C G Fathman.   

Abstract

Backcross nonobese diabetic (NOD) ((NOD x SWr)F1 x NOD) mice (108 females and 105 males) were typed for MHC, TCR V beta, and monitored for 350 days for the onset of diabetes. The presence of "antipolar" antibodies in the sera and the occurrence of insulitis was examined in a proportion of these backcross mice. There was no difference in the incidence of diabetes in mice heterozygous for TCR V beta b/a vs those homozygous for TCR V beta b/b. Among the 17 diabetics (all female) detected in this backcross, 14/17 were H-2nod/nod but 3/17 were H-2nod/q. This supports a previous observation suggesting that the MHC-linked diabetogenic gene originally thought to be recessive may rather be dominant but have a low penetrance in the heterozygous state. Antipolar autoantibodies were found in both female and male backcross mice, and were similarly distributed in diabetic and nondiabetic mice. There appeared to be no correlation between the level of these auto-antibodies and development of diabetes. The incidence and severity of insulitis was linked to MHC but no influence of TCR genes on insulitis nor an association between insulitis and antipolar antibodies could be demonstrated in this study. Further analyses of H-2nod/nod intercross mice homozygous for TCR V beta a or TCR V beta b are currently underway.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1824775

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

Review 1.  The differentiation of the immune system towards anti-islet autoimmunity. Clinical prospects.

Authors:  C Boitard
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

Review 2.  Cellular basis of T-cell autoreactivity in autoimmune diseases.

Authors:  C Carnaud; J F Bach
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

3.  Prevention of autoimmune insulitis in nonobese diabetic mice by expression of major histocompatibility complex class I Ld molecules.

Authors:  T Miyazaki; Y Matsuda; T Toyonaga; J Miyazaki; Y Yazaki; K Yamamura
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

4.  An Abd transgene prevents diabetes in nonobese diabetic mice by inducing regulatory T cells.

Authors:  S M Singer; R Tisch; X D Yang; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

5.  Restricted islet-cell reactive T cell repertoire of early pancreatic islet infiltrates in NOD mice.

Authors:  Felix J Baker; Mark Lee; Yueh-hsiu Chien; Mark M Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-24       Impact factor: 11.205

6.  A mechanism for the major histocompatibility complex-linked resistance to autoimmunity.

Authors:  D Schmidt; J Verdaguer; N Averill; P Santamaria
Journal:  J Exp Med       Date:  1997-10-06       Impact factor: 14.307

7.  Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice. The NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetes.

Authors:  L S Wicker; M C Appel; F Dotta; A Pressey; B J Miller; N H DeLarato; P A Fischer; R C Boltz; L B Peterson
Journal:  J Exp Med       Date:  1992-07-01       Impact factor: 14.307

8.  Genetic dissection of T cell receptor V beta gene requirements for spontaneous murine diabetes.

Authors:  J A Shizuru; C Taylor-Edwards; A Livingstone; C G Fathman
Journal:  J Exp Med       Date:  1991-09-01       Impact factor: 14.307

9.  Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice.

Authors:  L Wogensen; M S Lee; N Sarvetnick
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

10.  I-E+ nonobese diabetic mice develop insulitis and diabetes.

Authors:  P L Podolin; A Pressey; N H DeLarato; P A Fischer; L B Peterson; L S Wicker
Journal:  J Exp Med       Date:  1993-09-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.